CYP3A4 and steatosis: Because of the importance of CYP3A4 activity in steatosis development (Donato et al., 2006; Hu et al., 2014), we then determined whether CYP3A4 mediated the regulatory effect of miR-200a-3p or miR-150-5p inhibitor on FFA-induced steatosis.